Cell and Gene Therapy
The Birthplace of Cell and Gene Therapy
The Greater Philadelphia region is recognized worldwide as a leader in cell therapy, gene therapy, and gene editing. In fact, this is where the field started two decades ago and where it continues to rapidly grow. Our region’s commitment to R&D excellence and deep talent pool led to the first FDA-approved cell therapy and the first FDA-approved gene therapy.
Today, the Greater Philadelphia region is home to more than 45 cell and gene therapy development companies and countless research labs, as well as numerous contract research organizations and other supporting firms. Institutions including the University of Pennsylvania Perelman School of Medicine, Children’s Hospital of Philadelphia, Coriell Institute, Christiana Care Gene Editing Institute, Jefferson Health, Temple University, and the Wistar Institute contribute to the steady stream of scientific discoveries and technical expertise that underpin these companies. The subsector also benefits from a robust talent pipeline, with nearly 10,000 workers holding specific expertise in cell and gene therapy.
In addition, the highly collaborative nature of our larger life sciences ecosystem has fostered collaborations like the Cell & Gene Therapy and Connected Health Initiative, which features 11 partner companies, institutions, and universities in the Greater Philadelphia region. Together, our stakeholders are revolutionizing the future of healthcare.
Top: The Discovery Labs in King of Prussia hosts world-renowned life sciences institutions and innovative startups on their 2.8 million square-foot campus, with the ability to add up to 3 million square-feet. Below slideshow images courtesy of, in part: Drexel University; Lydia Polimeni, National Institutes of Health; PIDC; Princeton University, Office of Communications; and University of Pennsylvania Flickr.
James Medaglio, Director, Business Attraction & Expansion
With some of the lowest rental rates among Northeast metro areas, Greater Philadelphia is an attractive option for commercial real estate. See Available Sites ›
HHS Secretary Becerra Joins U.S. Senator Casey for Visit with Leaders in Greater Philadelphia’s Life Sciences Ecosystem
Greater Philadelphia has the assets and capacity to accelerate science and patient care in the next biotech revolution, and leaders in the region’s life sciences ecosystem had a chance to show that last week [...]
“Why Greater Philadelphia Ranks #2 As CGT Hub” Featured in Cell & Gene
The Chamber of Commerce for Greater Philadelphia commissioned a study conducted by Econsult Solutions, Inc., titled The State of Cell and Gene Therapy in the Greater Philadelphia Region: A Comparative Analysis, which measured the impact [...]
Comparative Study Ranks Philadelphia Region #2 Among 14 Cell and Gene Therapy Hubs
Philadelphia Region Now Tops Other Regional Hubs in Five Categories PHILADELPHIA (September 27, 2022) – In a newly released study comparing 14 U.S. cell and gene therapy hubs in five key categories, the Philadelphia region [...]